144 related articles for article (PubMed ID: 9406865)
41. D2- but not D1-dopamine receptors are involved in the inhibitory control of alpha-melanocyte-stimulating hormone release from the rat hypothalamus.
Tiligada E; Wilson JF
Exp Brain Res; 1989; 74(3):645-8. PubMed ID: 2540019
[TBL] [Abstract][Full Text] [Related]
42. Dopamine D(2)-like receptors selectively block N-type Ca(2+) channels to reduce GABA release onto rat striatal cholinergic interneurones.
Momiyama T; Koga E
J Physiol; 2001 Jun; 533(Pt 2):479-92. PubMed ID: 11389206
[TBL] [Abstract][Full Text] [Related]
43. Effects of opioid agonist drugs on the in vitro release of 3H-GABA, 3H-dopamine and 3H-5HT from slices of rat globus pallidus.
Dewar D; Jenner P; Marsden CD
Biochem Pharmacol; 1987 May; 36(10):1738-41. PubMed ID: 3297065
[No Abstract] [Full Text] [Related]
44. Functional uncoupling of adenosine A(2A) receptors and reduced responseto caffeine in mice lacking dopamine D2 receptors.
Zahniser NR; Simosky JK; Mayfield RD; Negri CA; Hanania T; Larson GA; Kelly MA; Grandy DK; Rubinstein M; Low MJ; Fredholm BB
J Neurosci; 2000 Aug; 20(16):5949-57. PubMed ID: 10934242
[TBL] [Abstract][Full Text] [Related]
45. [Effects of the stimulation of D1 and D2 dopaminergic receptors on the electrically induced release of gamma-(3H)-aminobutyric acid in the prefrontal cortex of the rat].
Penit-Soria J; Retaux S; Maurin Y
C R Acad Sci III; 1989; 309(10):441-6. PubMed ID: 2514970
[TBL] [Abstract][Full Text] [Related]
46. Experimental studies and theoretical aspects on A2A/D2 receptor interactions in a model of Parkinson's disease. Relevance for L-dopa induced dyskinesias.
Antonelli T; Fuxe K; Agnati L; Mazzoni E; Tanganelli S; Tomasini MC; Ferraro L
J Neurol Sci; 2006 Oct; 248(1-2):16-22. PubMed ID: 16765381
[TBL] [Abstract][Full Text] [Related]
47. Opposing roles of dopamine D1 and D2 receptors in nigral gamma-[3H]aminobutyric acid release?
Starr M
J Neurochem; 1987 Oct; 49(4):1042-9. PubMed ID: 2957468
[TBL] [Abstract][Full Text] [Related]
48. Electrophysiological verification of the presence of D1 and D2 dopamine receptors within the ventral pallidum.
Napier TC; Maslowski-Cobuzzi RJ
Synapse; 1994 Jul; 17(3):160-6. PubMed ID: 7974198
[TBL] [Abstract][Full Text] [Related]
49. Presynaptic D1 dopamine receptors facilitate glutamatergic neurotransmission in the rat globus pallidus.
Hernández A; Sierra A; Valdiosera R; Florán B; Erlij D; Aceves J
Neurosci Lett; 2007 Oct; 425(3):188-91. PubMed ID: 17845833
[TBL] [Abstract][Full Text] [Related]
50. The 5HT(1B) receptor agonist, CP-93129, inhibits [(3)H]-GABA release from rat globus pallidus slices and reverses akinesia following intrapallidal injection in the reserpine-treated rat.
Chadha A; Sur C; Atack J; Duty S
Br J Pharmacol; 2000 Aug; 130(8):1927-32. PubMed ID: 10952684
[TBL] [Abstract][Full Text] [Related]
51. Caffeine mimics the effect of a dopamine D2/3 receptor agonist on the expression of immediate early genes in globus pallidus.
Svenningsson P; Fredholm BB
Neuropharmacology; 1997 Sep; 36(9):1309-17. PubMed ID: 9364486
[TBL] [Abstract][Full Text] [Related]
52. Metabotropic glutamate mGlu5 receptor-mediated modulation of the ventral striopallidal GABA pathway in rats. Interactions with adenosine A(2A) and dopamine D(2) receptors.
Díaz-Cabiale Z; Vivó M; Del Arco A; O'Connor WT; Harte MK; Müller CE; Martínez E; Popoli P; Fuxe K; Ferré S
Neurosci Lett; 2002 May; 324(2):154-8. PubMed ID: 11988350
[TBL] [Abstract][Full Text] [Related]
53. GABAA receptor-mediated K(+)-evoked GABA release from globus pallidus--analysis using microdialysis.
Hashimoto T; Kuriyama K
Neurochem Int; 1997 Mar; 30(3):247-52. PubMed ID: 9041555
[TBL] [Abstract][Full Text] [Related]
54. Age-related modifications of the morphological organization of pituicytes are associated with alteration of the GABAergic and dopaminergic innervation afferent to the neurohypophysial lobe.
Alonso G; Runquist M; Hussy N; Duvoid A; Moos F
Eur J Neurosci; 2003 Oct; 18(7):1889-903. PubMed ID: 14622222
[TBL] [Abstract][Full Text] [Related]
55. Effects of exogenous and endogenous cannabinoids on GABAergic neurotransmission between the caudate-putamen and the globus pallidus in the mouse.
Engler B; Freiman I; Urbanski M; Szabo B
J Pharmacol Exp Ther; 2006 Feb; 316(2):608-17. PubMed ID: 16214880
[TBL] [Abstract][Full Text] [Related]
56. Differential dopaminergic regulation of the neurotensin striatonigral and striatopallidal pathways in the rat.
Castel MN; Morino P; Nylander I; Terenius L; Hökfelt T
Eur J Pharmacol; 1994 Sep; 262(1-2):1-10. PubMed ID: 7813560
[TBL] [Abstract][Full Text] [Related]
57. D-1 receptor mediated modulation of the release of gamma-aminobutyric acid by endogenous dopamine in the basal ganglia of the rat.
Aceves J; Floran B; Sierra A; Mariscal S
Prog Neuropsychopharmacol Biol Psychiatry; 1995 Sep; 19(5):727-39. PubMed ID: 8539416
[TBL] [Abstract][Full Text] [Related]
58. Dopamine D4 receptor modulates inhibitory transmission in pallido-pallidal terminals and regulates motor behavior.
Conde Rojas I; Acosta-García J; Caballero-Florán RN; Jijón-Lorenzo R; Recillas-Morales S; Avalos-Fuentes JA; Paz-Bermúdez F; Leyva-Gómez G; Cortés H; Florán B
Eur J Neurosci; 2020 Dec; 52(11):4563-4585. PubMed ID: 33098606
[TBL] [Abstract][Full Text] [Related]
59. Dopaminergic regulation of serotonin release in the substantia nigra of the freely moving rat using microdialysis.
Thorré K; Sarre S; Smolders I; Ebinger G; Michotte Y
Brain Res; 1998 Jun; 796(1-2):107-16. PubMed ID: 9689460
[TBL] [Abstract][Full Text] [Related]
60. [Endogenous dopamine modulates cortico-pallidal influence via GABA].
Raevskiĭ VV; Dawe GS; Stevenson JD
Ross Fiziol Zh Im I M Sechenova; 2002 Jun; 88(6):723-30. PubMed ID: 12154569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
